This inventor holds 2 USPTO granted patents. Top assignee: California Institute of Technology. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2006
Title: Innovations of Paulo Kofuji in Potassium Channel Research
Introduction
Paulo Kofuji is a prominent inventor based in Pasadena, CA, known for his significant contributions to the field of electrophysiology. His work primarily focuses on the development of functional mammalian inward rectifier, G-protein activated potassium channels. With a total of 2 patents, Kofuji's research has implications for drug screening and cellular modulation.
Latest Patents
Kofuji's latest patents include a method of inhibiting inward rectifier, G-protein activated, mammalian potassium channels. This invention provides compositions and methods for producing functional Kir3.0 channels, which are multimeric proteins comprising one or more Kir3.0 polypeptides. These channels exhibit unique features, such as conducting inward but not outward potassium current and being blocked by low concentrations of extracellular cesium or barium. The ability of these channels to conduct inward potassium current is modulated by G-proteins, which play a crucial role in signal transduction from receptors to the Kir3.0 channel.
Career Highlights
Kofuji is affiliated with the California Institute of Technology, where he continues to advance research in his field. His work has garnered attention for its potential applications in drug screening assays aimed at modulating cellular electrophysiology.
Collaborations
Some of Kofuji's notable coworkers include Henry A. Lester and Norman Davidson, who have contributed to the collaborative research environment that fosters innovation.
Conclusion
Paulo Kofuji's contributions to the understanding of potassium channels represent a significant advancement in the field of electrophysiology. His innovative patents and ongoing research continue to influence drug development and cellular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
